INANOBIO
INanoBiodevelop high-accuracy early-stage disease diagnostics using transformative nano-biotechnology platforms and machine learning. INanoBio is an Arizona State University (ASU) spinoff company, based in Tempe, Arizona, founded to commercialize FDEC FET nano sensor technology invented at ASU. The novel nanosensor technology is capable of exponential capacitive transduction for ultra-high sensitivity molecular detection, coupled with exceptional selectivity. Our proprietary technology can be u... sed in sensing of chemical and biological species with very low false positives and false negatives, for applications in health care diagnostics, industrial leak detection systems, and security. INanoBio is led by a strong team of scientists, managers, and eminent advisers. Currently, they are adding new members to their team. They have recently been awarded a multiyear federal grant for developing one of their advanced sensor technology platforms.
INANOBIO
Industry:
Biotechnology Nanotechnology Semiconductor
Founded:
2009-01-01
Address:
Tempe, Arizona, United States
Country:
United States
Website Url:
http://www.inanobio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.33 M USD
Technology used in webpage:
Google Apps For Business Microsoft Azure DNS
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Biocrucible
Biocrucible is developing next-generation diagnostics based upon breakthrough advances in biomolecular condensate formation.
Current Employees Featured
Founder
Official Site Inspections
http://www.inanobio.com
- Host name: 53.138.153.160.host.secureserver.net
- IP address: 160.153.138.53
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "INanoBio"
Home - INanoBio Inc
INanoBio’s sequencer will enable sequencing genomes of whole populations across the world. Cancer Diagnostics. Detecting diseases in early stages dramatically improves therapeutic outcomes. In Cancer, average 5 year …See details»
INanoBio - Crunchbase Company Profile & Funding
Organization. INanoBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... INanoBio is an …See details»
INanoBio - LinkedIn
INanoBio’s mission is to develop high-accuracy early stage disease diagnostics using transformative nano-biotechnology platforms and machine learning.See details»
INanoBio Company Profile 2025: Valuation, Funding
INanoBio General Information Description. Operator of a biotechnology and early-stage disease diagnostics company intended to develop a three-dimensional …See details»
INanoBio - Contacts, Employees, Board Members, Advisors & Alumni
INanoBiodevelop high-accuracy early-stage disease diagnostics using transformative nano-biotechnology platforms and machine learning.See details»
INanoBio - Company Profile - Tracxn
Dec 10, 2024 INanoBio, an Arizona State spinout, develops nanosensors for clinical diagnostics and genome sequencing. Its platform technology is a Fully Depleted Exponentially Coupled …See details»
INanoBio Inc - precisionmedicine.synapseconnect.org
INanoBio’s mission is to develop high-accuracy early stage disease diagnostics using transformative nano-biotechnology platforms and machine learning. Extract systems scale …See details»
INanoBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 21, 2018: Venture Round - …See details»
INanoBio | Phoenix, Arizona, US Startup - Gust
INanoBio is developing advanced nano sensor technologies for genome sequencing and personalized healthcare of the future. Stage Prototype Ready Industry Nanotechnology Location Phoenix, Arizona, US Currency USD …See details»
INanoBio Inc - VentureRadar
INanoBio is developing an advanced 3D nanopore – transistor device for sequencing the whole human genome with high accuracy, at one-tenth the current cost and time. Based on CMOS …See details»
INanoBio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore INanoBio, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 4 literature.See details»
INanoBio Company Profile - Office Locations, Competitors ... - Craft
INanoBio is a nanotech company that develops disease diagnostics solutions using transformative nano-biotechnology technology. It offers a 3D nanopore, a transistor device for sequencing the …See details»
iNanoBio - Products, Competitors, Financials, Employees, …
About iNanoBio. iNanoBio is a nano-biotechnology company focused on early stage disease diagnostics and genome sequencing. The company offers high-accuracy diagnostic tools that …See details»
INanoBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
INanoBiodevelop high-accuracy early-stage disease diagnostics using transformative nano-biotechnology platforms and machine learning.See details»
Director, Center for Personalized Medicine - INanoBio Inc
He is a medical oncologist, cancer researcher and nation’s leading proteomics expert. Dr. LaBaer was previously director of the Harvard Institute of Proteomics (HIP), he is founding member …See details»
INanoBio Expands Board - INanoBio Inc
Dr. Abhay Sanan and JP Million join INanoBio Board of Directors as part of 2018 Series Seed financing GENOME SEQUENCING Sequencing a person’s genome can identify susceptibility …See details»
INanoBio - Updates, News, Events, Signals & Triggers - Crunchbase
INanoBio may be growing as it has been profiled among key players in the nanopore technologies market, which is indicative of its recognition in the industry. The market in which INanoBio …See details»
INanoBio to Receive Up to $5.4 Million to Develop an Epigenetic ...
TEMPE, Ariz.--(BUSINESS WIRE)--INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine …See details»
INanoBio presenting at PMWC
INanoBio CEO, Bharath Takulapalli will be presenting at the Precision Medicine World Conference 2022 at the Santa Clara Convention Center. GENOME SEQUENCING …See details»
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key …
2 days ago Progressed commercial readiness plans to be launch ready by the end of 2025, including: refining go-to-market strategy focused on patient and physician needs; driving key …See details»